LncRNA DLX6-AS1 Contributes to Epithelial–Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis

LncRNA DLX6-AS1 Contributes to Epithelial–Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis

Triple-negative breast cancer (TNBC) is one of the most aggressive cancer types with high recurrence, metastasis, and drug resistance. Recent studies report that long noncoding RNAs (lncRNAs)-mediated competing endogenous RNAs (ceRNA) play an important role in tumorigenesis and drug resistance of TN...

Full description

Bibliographic Details
Main Authors: Chuang Du, Yan Wang, Yingying Zhang, Jianhua Zhang, Linfeng Zhang, Jingruo Li
Format: Article
Language:English
Published: SAGE Publishing 2020-07-01
Series:Cell Transplantation
Online Access:https://doi.org/10.1177/0963689720929983

Internet

https://doi.org/10.1177/0963689720929983

Similar Items